Development of Venous Thromboembolism After COVID-19 mRNA-1273 Vaccine Inoculation.

covid vaccines covid-19 mrna-1273 vaccine vaccine induced thrombosis venous thromboembolism

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
Feb 2022
Historique:
accepted: 13 02 2022
entrez: 21 3 2022
pubmed: 22 3 2022
medline: 22 3 2022
Statut: epublish

Résumé

A 79-year-old man suddenly developed right lower extremity (RLE) pain and swelling a few days after receiving his 1st dose of the mRNA-1273 COVID-19 vaccine. Despite this, he proceeded to receive the 2nd dose of his mRNA-1273 COVID-19 vaccine. Investigations confirmed extensive acute deep venous thrombosis and a concurrent acute pulmonary embolism. Therapeutic anticoagulation was initiated and he was eventually discharged home on supplemental oxygen. The overall benefits of the vaccine in curbing severe disease overwhelmingly outweigh the handful of cases of reported adverse events. To our knowledge, this is one of the first few cases of provoked venous thrombosis after receiving the mRNA-1273 COVID-19 vaccine during the pharmacovigilance period.

Identifiants

pubmed: 35308698
doi: 10.7759/cureus.22179
pmc: PMC8923564
doi:

Types de publication

Case Reports

Langues

eng

Pagination

e22179

Informations de copyright

Copyright © 2022, Mahgoub et al.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Am J Hematol. 2020 Dec;95(12):1522-1530
pubmed: 32833259
MMWR Morb Mortal Wkly Rep. 2021 Jan 15;70(2):46-51
pubmed: 33444297
Eur J Vasc Endovasc Surg. 2003 Jan;25(1):1-5
pubmed: 12525804
Lancet Haematol. 2022 Jan;9(1):e73-e80
pubmed: 34774202
Front Med (Lausanne). 2021 Nov 01;8:772424
pubmed: 34790684
BMJ. 2021 Aug 26;374:n1931
pubmed: 34446426
Eur J Neurol. 2021 Nov;28(11):3656-3662
pubmed: 34293217
Expert Opin Drug Saf. 2021 Nov;20(11):1451-1453
pubmed: 34264151
Ann Epidemiol. 2021 May;57:14-21
pubmed: 33662494
BMJ. 2021 May 5;373:n1114
pubmed: 33952445
Ann Intern Med. 2021 Oct;174(10):1480-1482
pubmed: 34181446
Am J Case Rep. 2021 Jun 12;22:e932946
pubmed: 34117206
Am J Hematol. 2021 Sep 1;96(9):E357-E361
pubmed: 34133027
N Engl J Med. 2021 Feb 4;384(5):403-416
pubmed: 33378609
Lancet Infect Dis. 2020 May;20(5):533-534
pubmed: 32087114

Auteurs

Abdullahi E Mahgoub (AE)

Internal Medicine, Hurley Medical Center, Flint, USA.
College of Human Medicine, Michigan State University, Lansing, USA.

Dominic Awuah (D)

Internal Medicine, Hurley Medical Center, Flint, USA.
College of Human Medicine, Michigan State University, Lansing, USA.

MurtazaShabbir Hussain (M)

Internal Medicine, Hurley Medical Center, Flint, USA.
College of Human Medicine, Michigan State University, Lansing, USA.

Smit Deliwala (S)

Internal Medicine, Hurley Medical Center, Flint, USA.
College of Human Medicine, Michigan State University, Lansing, USA.

Ghassan Bachuwa (G)

Internal Medicine, Hurley Medical Center, Flint, USA.
College of Human Medicine, Michigan State University, Lansing, USA.

Mariam Younas (M)

Infectious Diseases, Hurley Medical Center, Flint, USA.
College of Human Medicine, Michigan State University, Lansing, USA.

Classifications MeSH